Skip to main content
main-content

Zeitschrift

Investigational New Drugs

Investigational New Drugs 2/2000

Ausgabe 2/2000

Inhaltsverzeichnis ( 9 Artikel )

01.05.2000 | Ausgabe 2/2000

UCN-01 Enhances the In Vitro Toxicity of Clinical Agents in Human Tumor Cell Lines

Anne Monks, Erik D. Harris, Anne Vaigro-Wolff, Curtis D. Hose, John W. Connelly, Edward A. Sausville

01.05.2000 | Ausgabe 2/2000

Proteasome Inhibition: a New Strategy in Cancer Treatment

Julian Adams, Vito J. Palombella, Peter J. Elliott

01.05.2000 | Ausgabe 2/2000

DNA G-Quadruplexes, Telomere-Specific Proteins and Telomere-Associated Enzymes as Potential Targets for New Anticancer Drugs

Eric Raymond, Jean-Charles Soria, Elzbieta lzbicka, Francois Boussin, Laurence Hurley, Daniel D. Von Hoff

01.05.2000 | Ausgabe 2/2000

Cytotoxic Effects of Topotecan Combined with Various Active G2/M-Phase Anticancer Drugs in Human Tumor-Derived Cell Lines

Miquel Taron, Carmen Plasencia, Albert Abad, Cristina Martin, Mónica Guillot

01.05.2000 | Ausgabe 2/2000

Cdc25 as a Potential Target of Anticancer Agents

Jens W. Eckstein

01.05.2000 | Ausgabe 2/2000

Chemotherapy in Non-Small Cell Lung Cancer

Christopher J. Sweeney, Alan B. Sandler

01.05.2000 | Ausgabe 2/2000

CI-980 in Advanced Melanoma and Hormone Refractory Prostate Cancer

Christopher W. Ryan, Keith L. Shulman, Jon M. Richards, John W. Kugler, Jeffrey A. Sosman, Rafat H. Ansari, Everett E. Vokes, Nicholas J. Vogelzang

01.05.2000 | Ausgabe 2/2000

A Phase II Pilot Study of KW-2189 in Patients with Advanced Renal Cell Carcinoma

Eric J. Small, Robert Figlin, Daniel Petrylak, David J. Vaughn, Oliver Sartor, Ivan Horak, Rosemarie Pincus, Alton Kremer, Chris Bowden

01.05.2000 | Ausgabe 2/2000

A Phase II Trial of Topotecan in Esophageal Carcinoma: A Southwest Oncology Group Study (SWOG 9339)

John S. Macdonald, Joth L. Jacobson, Steven J Ketchel, Geoffrey Weiss, Sarah Taylor, Glenn Mills, J. Phillip Kuebler, Saul Rivkin, Marcel Conrad

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise